Alembic Pharma receives USFDA approval for generic ear infection drug
The product is indicated for the treatment of certain ear infections in paediatric patients aged six months and older, as well as adults and elderly patients
We haven't written up this one. Business Standard IN has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.